Real-time enrollment status for this migraine disorders clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT06735833 |
| Recruiting Status | Recruiting |
| Condition | Migraine Disorders |
| Phase | NA |
| Target Enrollment | 70 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Cerenovus, Part of DePuy Synthes Products, Inc. |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT06735833 is currently recruiting participants. This na study for migraine disorders is actively seeking new participants at 8 locations across the United States. The study is sponsored by Cerenovus, Part of DePuy Synthes Products, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06735833 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06735833 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.